Lab Report Analysis + Clinical Assessment

Patient Details

• Name: Dr. Abel Varughese Prasad | Age: 21 years / Male
• Referred by: Dr. Sakthivel Sivasubramanian, DM (Endocrinology)
• Collected: 01/06/2026

Key Lab Abnormalities

Hormonal Panel - The Core Findings

Other Labs

Clinical Interpretation of Abnormalities

1. Hyperprolactinemia (Prolactin = 16.50 ng/mL, High)

2. Elevated Estradiol (69.85 pg/mL, High)

• Peripheral aromatization of testosterone to estradiol (e.g., in adipose tissue)
• Hyperprolactinemia-associated dysregulation

• Suppresses LH secretion via negative feedback on the pituitary (even though LH here is still normal, the suppressive pressure reduces LH pulse amplitude)
• Directly antagonizes androgen action at target tissues (muscle, hair follicles, erectile tissue)
• Inhibits 5-alpha reductase activity, reducing DHT formation that is responsible for facial/body hair growth and libido
• Explains poor facial hair growth and impaired muscle development by competing with testosterone at the androgen receptor

3. Functional Hypogonadism Pattern

• Elevated prolactin suppressing the HPT axis
• Elevated estradiol competing with testosterone at target tissues
• Low-normal FSH (2.33) reflecting suppressed gonadotropin drive

Possible Diagnoses to Consider

1. Hyperprolactinemia - likely idiopathic or from a microadenoma (pituitary prolactinoma). An MRI of the pituitary sella is warranted to rule out a space-occupying lesion.
2. Functional hypogonadism secondary to hyperprolactinemia + hyperestrogenism
3. Possible aromatase excess - causing excess estradiol production from testosterone
4. Medications, stress, or hypothyroidism can also cause mild hyperprolactinemia (thyroid here is normal, ruling out the last cause)

Treatment Options

Step 1: Address the Root Cause - Hyperprolactinemia

• Cabergoline (0.25-0.5 mg twice weekly) - preferred agent; causes less nausea than bromocriptine, more effective, and longer acting. FDA-approved for hyperprolactinemic disorders. (Katzung Pharmacology 16th Ed.)
• Bromocriptine (2.5-7.5 mg/day in divided doses) - older agent, also effective; may be preferred in women of reproductive age due to better safety data in pregnancy

Step 2: Address Elevated Estradiol (if persistent after prolactin normalization)

• Aromatase inhibitors (e.g., anastrozole, letrozole) can be considered if estradiol remains elevated, especially if peripheral aromatization is the primary driver
• Weight management (reducing adipose tissue reduces aromatase activity)

Step 3: Pituitary MRI

• Rule out a prolactinoma (microadenoma vs. macroadenoma)
• Guide the duration and intensity of dopamine agonist therapy

Step 4: Testosterone Replacement Therapy (if needed)

Step 5: PDE-5 Inhibitor for Erectile Dysfunction (adjunct)

• Sildenafil (Viagra), tadalafil (Cialis), or vardenafil can be used as adjunctive therapy for erectile dysfunction while awaiting hormonal correction
• These are first-line agents for ED regardless of etiology (Textbook of Family Medicine 9e; Goldman-Cecil: "Treatment with a phosphodiesterase-5 inhibitor is effective therapy for most men with erectile dysfunction")

Summary

HCG Injections in This Patient - A Detailed Assessment

What HCG Does

• TRT - bypasses the HPT axis entirely, suppresses LH/FSH via negative feedback, leads to testicular atrophy and azoospermia
• HCG - works through the axis, maintains intratesticular testosterone, preserves testicular volume and spermatogenesis

Is HCG Appropriate for This Patient?

Arguments FOR using HCG

1. Age (21 years old) - fertility preservation is paramount. This is the strongest argument for hCG over TRT. Exogenous testosterone at age 21 suppresses FSH and LH, causes testicular atrophy, and can take months to years to recover spermatogenesis after stopping. HCG avoids all of this.
2. Functional hypogonadotropic pattern. The patient's FSH is low-normal (2.33 mIU/mL), and his LH, while within range, shows the HPT axis is not robustly stimulated. HCG would directly bypass the suppressed pituitary drive and stimulate Leydig cells.
3. Maintains testicular size and endogenous function. Campbell Walsh Wein Urology (19th Ed.) confirms: "Treatment includes replacement of LH with human chorionic gonadotropin (hCG)... Treatment with hCG alone may initiate spermatogenesis."
4. Typical doses: 1,500-5,000 IU IM or SC, 2-3 times weekly, titrated to serum testosterone levels (max 10,000 IU/week). - Campbell Walsh Wein Urology, p. 1917
5. Per the 2026 Joint Brazilian Society Position Statement (PMID: 41678706), fertility-preserving strategies including hCG are explicitly recommended when fertility is a concern in male hypogonadism patients.

The Critical Concern FOR THIS SPECIFIC PATIENT: HCG + Already-Elevated Estradiol

"hCG stimulates testicular aromatase activity and estrogen production, resulting in gynecomastia."

• Tietz Textbook of Laboratory Medicine, 7th Ed.

• HCG stimulates Leydig cells to produce testosterone, but it simultaneously upregulates testicular aromatase - the enzyme that converts testosterone to estradiol
• This patient's estradiol is already elevated; HCG therapy would likely push it further upward
• Higher estradiol would:
  • Further suppress the HPT axis (worsening the gonadotropin suppression)
  • Worsen erectile dysfunction and libido through anti-androgenic effects
  • Risk gynecomastia development
  • Potentially paradoxically worsen symptoms despite rising testosterone

The Root Cause Must Be Treated First: Hyperprolactinemia

• Prolactin continues to suppress GnRH/LH pulsatility
• Prolactin has direct inhibitory effects on Leydig cell function (prolactin receptors exist on Leydig cells and impair testosterone biosynthesis)
• Even if hCG forces some testosterone production, the functional environment remains hostile to androgenic action

1. Cabergoline first - normalize prolactin, which may restore LH pulsatility and reduce estradiol
2. Reassess testosterone, estradiol, FSH, LH after 3 months
3. If gonadotropins remain suppressed and symptoms persist - then add hCG (with co-administration of an aromatase inhibitor like anastrozole to blunt the estradiol rise)

Practical HCG Protocol (If Indicated After Prolactin Normalization)

HCG vs. TRT - Summary Table for This 21-Year-Old

Bottom Line